HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

David M Hansell Selected Research

cyclopropapyrroloindole

11/2017Evaluation of visual and computer-based CT analysis for the identification of functional patterns of obstruction and restriction in hypersensitivity pneumonitis.
9/2017Unclassifiable-interstitial lung disease: Outcome prediction using CT and functional indices.
5/2017Chronic hypersensitivity pneumonitis: identification of key prognostic determinants using automated CT analysis.
9/2016Automated Quantitative Computed Tomography Versus Visual Computed Tomography Scoring in Idiopathic Pulmonary Fibrosis: Validation Against Pulmonary Function.
2/2014An integrated clinicoradiological staging system for pulmonary sarcoidosis: a case-cohort study.
4/2007Quantification of emphysema: a composite physiologic index derived from CT estimation of disease extent.
4/2003Idiopathic pulmonary fibrosis: a composite physiologic index derived from disease extent observed by computed tomography.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


David M Hansell Research Topics

Disease

18Bronchiectasis
09/2017 - 08/2003
16Emphysema
05/2017 - 03/2003
10Interstitial Lung Diseases (Interstitial Lung Disease)
11/2017 - 04/2003
10Idiopathic Pulmonary Fibrosis
01/2017 - 04/2003
7Fibrosis (Cirrhosis)
09/2017 - 05/2003
5Disease Progression
05/2016 - 04/2013
4Lung Diseases (Lung Disease)
09/2015 - 12/2011
4Sarcoidosis (Schaumann Disease)
09/2015 - 01/2011
4Chronic Obstructive Pulmonary Disease (COPD)
01/2015 - 07/2009
4Infections
08/2014 - 05/2003
4Bronchiolitis
12/2011 - 06/2002
4Pulmonary Fibrosis (Fibrosing Alveolitis)
12/2008 - 04/2003
3Extrinsic Allergic Alveolitis (Hypersensitivity Pneumonitis)
09/2015 - 08/2012
3Pulmonary Emphysema
03/2013 - 06/2002
3Pulmonary Hypertension
06/2011 - 06/2007
2Pulmonary Aspergillosis
06/2020 - 03/2014
2Pneumonia (Pneumonitis)
04/2014 - 04/2003
2Pulmonary Sarcoidosis
02/2014 - 01/2011
2Systemic Scleroderma (Systemic Sclerosis)
05/2013 - 04/2013
2Heart Failure
04/2003 - 07/2002
1Organizing Pneumonia
05/2016
1Lung Injury
05/2016
1Hyperplasia
10/2015
1Glycogen Storage Disease (Glycogenosis)
10/2015
1Pneumothorax
09/2015
1Cystic Fibrosis (Mucoviscidosis)
09/2015
1Diarrhea
05/2014
1Neoplasms (Cancer)
04/2014
1Lung Neoplasms (Lung Cancer)
02/2014
1Inflammation (Inflammations)
06/2013
1Cysts
03/2013
1Connective Tissue Diseases (Connective Tissue Disease)
09/2012
1Asbestosis
01/2007
1Vascular Diseases (Vascular Disease)
07/2005
1Pulmonary Tuberculosis
05/2004
1Tuberculosis (Tuberculoses)
05/2004
1Crohn Disease (Crohn's Disease)
05/2004
1Dyspnea (Shortness of Breath)
02/2004
1Respiratory Sounds (Crackle)
02/2004
1Langerhans-Cell Histiocytosis (Histiocytosis, Langerhans Cell)
08/2003
1Hamman-Rich Syndrome (Hamman Rich Syndrome)
05/2003
1Obstructive Lung Diseases (Obstructive Lung Disease)
06/2002
1Asthma (Bronchial Asthma)
06/2002

Drug/Important Bio-Agent (IBA)

8Carbon MonoxideIBA
01/2017 - 02/2004
7cyclopropapyrroloindoleIBA
11/2017 - 04/2003
4nintedanibIBA
01/2017 - 09/2011
3Oxygen (Dioxygen)IBA
01/2015 - 05/2003
3Rituximab (Mabthera)FDA Link
04/2014 - 09/2012
3Indicators and Reagents (Reagents)IBA
06/2011 - 07/2002
2Transfer Factor (Factor, Transfer)IBA
05/2014 - 05/2013
2beta-cyclodextrin tetradecasulfate (CTDS)IBA
04/2014 - 05/2003
2Biomarkers (Surrogate Marker)IBA
06/2013 - 04/2013
2SmokeIBA
10/2003 - 08/2003
1EchinocandinsIBA
06/2020
1AzolesIBA
06/2020
1FibrinIBA
05/2016
1Adrenal Cortex Hormones (Corticosteroids)IBA
05/2016
1Anti-Bacterial Agents (Antibiotics)IBA
12/2015
1Proteins (Proteins, Gene)FDA Link
10/2015
1Surface-Active Agents (Surfactants)IBA
10/2015
1BombesinIBA
10/2015
1salicylhydroxamic acid (SHAM)IBA
09/2015
1Deoxyglucose (2 Deoxy D glucose)IBA
09/2015
1DNA (Deoxyribonucleic Acid)IBA
09/2015
1Liposomes (Liposome)IBA
09/2015
1Clostridium perfringens epsilon-toxinIBA
01/2015
1Monoclonal AntibodiesIBA
04/2014
1Antifungal AgentsIBA
03/2014
1Caspofungin (Cancidas)FDA Link
03/2014
1TriazolesIBA
03/2014
1A-factor (Streptomyces)IBA
02/2014
1MucinsIBA
05/2013
1Mucin-5BIBA
05/2013
1Interleukin-10 (Interleukin 10)IBA
04/2013
1Interleukin-6 (Interleukin 6)IBA
04/2013
1CytokinesIBA
04/2013
1Interleukin-8 (Interleukin 8)IBA
04/2013
1Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
04/2013
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
04/2013
14- ((1,4,8,11- tetraazacyclotetradec- 1- yl)methyl)benzoic acidIBA
05/2012
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
09/2011
1Tyrosine Kinase InhibitorsIBA
09/2011
1GoldIBA
07/2009
1AsbestosIBA
01/2007
1CollagenIBA
07/2005
1Tuberculin (PPD)IBA
05/2004
1Azathioprine (Imuran)FDA LinkGeneric
05/2004
1Venlafaxine Hydrochloride (Effexor)FDA LinkGeneric
04/2003
1Antidepressive Agents (Antidepressants)IBA
04/2003
1N 30IBA
06/2002

Therapy/Procedure

16Traction
09/2017 - 08/2003
6Therapeutics
06/2020 - 05/2004
6Pneumonectomy (Lung Volume Reduction)
09/2015 - 03/2003
1Aftercare (After-Treatment)
04/2014
1Bone Marrow Transplantation (Transplantation, Bone Marrow)
12/2011
1Lung Transplantation
01/2011
1Cardiac Catheters
01/2011